Atlas Trials

Non-transfusion Dependent Thalassemia

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Non-transfusion Dependent Thalassemia

RecordFirmDate
A Study Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124 in Adults With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome (NCT04718844)Silence Therapeutics plc2021-04-14
Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia (NCT04364269)Vifor (International) Inc.2020-06-11
Study in Beta-thalassaemia or Myelodysplastic Syndrome Patients to Investigate the Safety and Tolerability of SLN124 (NCT04176653)Silence Therapeutics plc2019-08-20
Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet (NCT02993224)Novartis Pharmaceuticals2017-07-27
Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia (NCT01709838)Novartis Pharmaceuticals2012-12-06
Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension Study (NCT00873041)Novartis Pharmaceuticals2008-11-01

Track Non-transfusion Dependent Thalassemia automatically

Every clearance here is in the API, with alerts when new ones post.